JRCT ID: jRCT1030230122
Registered date:08/06/2023
A Study on Optimizing Setup Margins in Carbon Ion Radiotherapy
Basic Information
Recruitment status | Recruiting |
---|---|
Health condition(s) or Problem(s) studied | Lung cancer, prostate cancer, liver cancer, breast cancer, kidney cancer |
Date of first enrollment | 01/06/2023 |
Target sample size | 750 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Systematically organize the deviations and trends in marker positions for each treated organ, pre-treatment, and irradiated body position, and determine the setup margin for each condition. |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | |
Include criteria | Patients treated with Carbon-ion radiotherapy for lung, prostate, liver, breast, and kidney at QST Hospital between March 2020 and February 2023 after gold marker insertion are eligible. |
Exclude criteria | 1. Patients whose gold marker location information is not stored. 2. Patients who have requested to refuse the use of their information for this study. |
Related Information
Primary Sponsor | Okonogi Noriyuki |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Noriyuki Okonogi |
Address | 4-9-1 Anagawa, Inage-ku, Chiba City, Chiba Chiba Japan 263-8555 |
Telephone | +81-43-206-3306 |
okonogi.noriyuki@qst.go.jp | |
Affiliation | National Institutes for Quantum Science and Technology |
Scientific contact | |
Name | Noriyuki Okonogi |
Address | 4-9-1 Anagawa, Inage-ku, Chiba City, Chiba Chiba Japan 263-8555 |
Telephone | +81-43-206-3306 |
okonogi.noriyuki@qst.go.jp | |
Affiliation | National Institutes for Quantum Science and Technology |